cabozantinib,atezolizumab,Pembrolizumab,Lenvatinib,Sunitinib,Everolimus
Merck,Pfizer,Eisai,roche
['contact-03', 'rcc,(-irccs),(-srcc),(-urcc)']
food for thought on the best way to choose front-line for ccrcc. contact-03, clear. 
Med Onc Resident 🇵🇹